Health Care/Hospital

Wound Care Plus, LLC Revolutionizes Wound Management with ARANZ Medical's Silhouette Solution

CHRISTCHURCH, New Zealand, April 15, 2024 /PRNewswire/ -- Wound Care Plus, LLC, a leading provider of mobile wound care services in the US, has announced a groundbreaking partnership with ARANZ Medical to integrate ARANZ Medical's innovative Silhouette wound assessment solution into their wound c...

2024-04-15 20:00 658

TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S CELL THERAPY PROGRAM AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

TreeFrog Therapeutics reports on the first bioproduction of a cell therapy for Parkinson's Disease in a scalable bioreactor1 BORDEAUX, France, April 15, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a cell therapy development company with its lead program in Parkinson's Disease is presenting for t...

2024-04-15 15:30 779

GenScript Biotech officially joins SBTi to fulfill its sustainability commitment

PISCATAWAY, N.J., April 15, 2024 /PRNewswire/ -- On April 15, GenScript Biotech Corporation ("GenScript"), a world's leading technology and service provider of life science R&D and manufacture, announced that it has joined The Science Based Targets initiative (SBTi) and submitted the Science Base...

2024-04-15 15:04 715

NEW HEALTH RESORT BY CLINIQUE LA PRAIRIE TO OPEN IN TRI VANANDA, PHUKET

New Wellness Residential Community and Resort on the Forefront of Luxury Multi-Generational Living and Longevity PHUKET, Thailand, April 15, 2024 /PRNewswire/ -- Clinique La Prairie and Montara Hospitality Group are delighted to announce their partnership and the opening of a new Health Resort b...

2024-04-15 14:50 858

DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO

SINGAPORE, April 15, 2024 /PRNewswire/ -- Respiree announced today that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @South San Francisco[1] from February 12, 2024. By expanding footprint within the US, Respiree aims to deepen its relationships ...

2024-04-15 14:15 791

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA

– Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant – – World Hepatitis Alliance Supports Global Expansion of Gilead ALL4LIVER Grant by Joining Grant Review Committee – – South Korea's Association of Liver Patients and Survivors and the Taiwan re...

2024-04-15 13:06 1002

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN HONG KONG

-- Gilead Awards US$4 Million Globally (Excluding the United States) Through The Gilead ALL4LIVER Grant -- -- World Hepatitis Alliance Supports Global Expansion of Gilead ALL4LIVER Grant by Joining Grant Review Committee -- -- Hong Kong Liver Foundation and Hong Kong Liver Transplant Patients' ...

2024-04-15 12:22 986

Singapore investors remain active, and excited about AI and structural themes

A survey by Fullerton Fund Management found that 97% were actively invested in the past 12 months, with the majority favouring a mix of safe haven assets and equities  SINGAPORE, April 15, 2024 /PRNewswire/ -- A survey by Fullerton Fund Management has revealed that 97% ofSingapore investors rema...

2024-04-15 09:00 794

Bloomage Demonstrates Global Quality Management Excellence through On-Site Audit by Japan's PMDA

TOKYO, April 15, 2024 /PRNewswire/ -- Bloomage recently successfully completed the on-site Good Manufacturing Practice (GMP) audit conducted byJapan's Pharmaceuticals and Medical Devices Agency (PMDA).  As the official regulatory agency for pharmaceuticals inJapan, the PMDA holds significant resp...

2024-04-15 08:30 882

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

SHANGHAI, April 13, 2024 /PRNewswire/ -- On Apr. 11, 2024, VITAL HealthCare, one of the 5 core business divisions of the VITAL Group, marked a stunning debut at the 89th China International Medical Equipment Fair (CMEF) inShanghai. Drawing on the Group's core competence in R&D and its wealth of t...

2024-04-13 20:00 2459

【2024 AACR Late Breaking Research】TransThera announces clinical data of tinengotinib to treat patients with advanced solid tumors harboring actionable FGFR1-3 alterations

NANJING, China and GAITHURSBURG, Md., April 12, 2024 /PRNewswire/ -- TransThera Sciences, a clinical-stage biopharmaceutical company focused on inventing differentiated drugs for global patients, announced the poster presentation at the 2024 American Association for Cancer Research (AACR) to disc...

2024-04-12 21:00 1590

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

Second major trial for atrial shunt therapy demonstrates importance of patient selection TEWKSBURY, Mass., April 12, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the recent release of V-Wave's RELIEVE-HF trial data support...

2024-04-12 13:00 1150

Healthcare Revolution 2024: Largest Industry Event Moves to Drive Superior Results in Healthcare and Medical Tourism

PALM BEACH GARDENS, Fla., April 11, 2024 /PRNewswire/ -- The largest annual gathering of key stakeholders in medical travel, healthcare leaders, and self-funded employers is back this year with an exciting new move to help stakeholders achieve superior results, elevate their programs, and redefin...

2024-04-11 23:36 1483

Empowering Lives with COOLiFY: TORRAS Joins Forces with Autistic Families to Advance Technological Excellence and Foster a Deep Sense of Love and Care

NEW YORK, April 11, 2024 Capitalizing on the global significance of World Autism Awareness Day onApril 2nd, TORRAS, in tandem with the promotion of COOLiFY Cyber's latest offerings, has crafted an innovative campaign that seamlessly integrates brand mission with social responsibility: "Stay Cool ...

2024-04-11 22:00 1129

Fosun's Subsidiary Fidelidade Announces Listing Plan of Private Health Service Company Luz Saúde

HONG KONG, April 11, 2024 /PRNewswire/ -- Fidelidade, a subsidiary of Fosun International andPortugal's leading insurer, announced on Wednesday (10 April) that its subsidiary, Luz Saúde, a private healthcare service provider had communicated to the market its plan to seek admission for the tradin...

2024-04-11 17:14 3037

Don't Miss Out - Join the 7th IFPA Conference: Uncovering the Broad Spectrum of Psoriatic Disease

STOCKHOLM, April 11, 2024 /PRNewswire/ -- IFPA is delighted to announce the 7th IFPA Conference set to take place fromJune 27th to June 29th, 2024, in the picturesque city ofStockholm, Sweden. This year's conference promises to be a pivotal event for experts and stakeholders in the field of psori...

2024-04-11 16:00 1229

Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan

HELSINKI, Finland, April 11, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform") today announced a strategic partnership whereby CBC Co., Ltd. ("CBC"), will utilize its extensive experience in the Japanese pharmaceutical industry to identify opportunities for Nanoform's cutting-edge nanomedici...

2024-04-11 15:38 1236

Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer

SINGAPORE and PHILADELPHIA, April 11, 2024 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnology company dedicated to developing novel medicines to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment ofDr. John Lee, MD, PhD, as its Chief Medical Office...

2024-04-11 14:59 1321

J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study

SEOUL, South Korea, April 11, 2024 /PRNewswire/ -- J INTS BIO announced the results of its ongoing Phase 1 clinical study of JIN-A02, a 4th generation EGFR-TKI for NSCLC treatment, at the 8th April poster session of the 2024 American Cancer Research Society (AACR) Annual Meeting held inSan Diego,...

2024-04-11 14:56 1008

St. Joseph's Children's Hospital Foundation Receives Historic $50 Million Gift from the Pagidipati Family of Tampa

TAMPA, Fla., April 11, 2024 /PRNewswire/ -- St. Joseph's Children's Hospital Foundation announced today a$50 million gift from the Pagidipati family of Tampa to support the future of pediatric health care in theTampa Bay community. Tampa business leader and philanthropistSidd Pagidipati, along wi...

2024-04-11 09:18 1209
12345 ... 805